Identification of serum protein biomarkers in individuals with Niemann-Pick disease, type C1.
Khushboo Singhal, Matthew T Menold, Niamh X Cawley...
https://pubmed.ncbi.nlm.nih.gov/42052237/Actively Recruiting
Led by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) · Updated on 2026-10-26
900
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are studying Niemann-Pick Disease, Type C NPC, a rare genetic disorder that causes progressive loss of nervous system function. This research aims to find clinical and laboratory markers that could help measure response to new treatments and better understand how NPC progresses over time. The study includes patients of all ages with NPC and also involves healthy volunteers or carriers for comparison purposes. Participants undergo evaluations every six months during 4- to 5-day stays at the NIH Clinical Center. These evaluations include medical history review, physical and neurological exams, neuropsychometric tests, blood and urine tests, lumbar puncture to collect cerebrospinal fluid, eye exams including eye movement studies, hearing tests, electroretinography to measure retina function, and brain MRI scans. Patients also complete questionnaires and may have photographs taken for educational or scientific use with consent. Female participants over age 10 have pregnancy tests at each admission. During the study, researchers monitor clinical signs and biochemical markers, including plasma oxysterols, to assess disease progression and treatment response. Safety and tolerability are evaluated through physical exams and laboratory tests. Participants may be recognized in photographs but not identified by name. The study provides detailed data to help define NPC progression and support future treatment trials, with visits every six months and various medical assessments during each admission.
CONDITIONS
Evaluation of Biochemical Markers and Clinical Investigation of Niemann-Pick Disease, Type C
D
Derek M Alexander
F
Forbes D Porter, M.D.
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Every 6 months
Participants undergo comprehensive medical and neurological exams, lumbar punctures, eye exams, hearing tests, electroretinography, brain MRI scans, and complete questionnaires every six months during 4- to 5-day admissions at the NIH Clinical Center.
Each admission lasts 4 to 5 days
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Khushboo Singhal, Matthew T Menold, Niamh X Cawley...
https://pubmed.ncbi.nlm.nih.gov/42052237/Audrey Thurm, Colby Chlebowski, Lisa Joseph...
https://pubmed.ncbi.nlm.nih.gov/32073546/Beth I Solomon, Andrew C Smith, Ninet Sinaii...
https://pubmed.ncbi.nlm.nih.gov/32897301/Khushboo Singhal, Matthew T Menold, Niamh X Cawley...
https://pubmed.ncbi.nlm.nih.gov/42106890/Khushboo Singhal, Matthew T Menold, Niamh X Cawley...
https://pubmed.ncbi.nlm.nih.gov/41742944/Beth I Solomon, Andrea M Muñoz, Ninet Sinaii...
https://pubmed.ncbi.nlm.nih.gov/36064725/Cristan Farmer, Monica Lewis, Nicole Farhat...
https://pubmed.ncbi.nlm.nih.gov/40525490/Beth I Solomon, Andrea M Muñoz, Ninet Sinaii...
https://pubmed.ncbi.nlm.nih.gov/38863022/Kiersten Campbell, Niamh X Cawley, Rachel Luke...
https://pubmed.ncbi.nlm.nih.gov/36721240/Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Lead Sponsor